| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 193,000 | 140,000 | 195,000 | 139,000 | | Cost of Revenue | (100,000) | 100,000 |
-
| 41,000 | | | Gross Profit | 293,000 | 40,000 | 195,000 | 98,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 175,000 | (29,000) | 79,000 | 31,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (79,000) | 69,000 | 116,000 | 67,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 45,000 | (567,000) | (611,000) | (1,649,000) | | Earnings Before Interest And Taxes | 118,000 | 69,000 | 116,000 | 146,000 | | Interest Expense | 85,000 | 60,000 | 52,000 | 59,000 | | Income Before Tax | 33,000 | 9,000 | 64,000 | 87,000 | | Income Tax Expense | 1,000 | (11,000) |
-
| 43,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,222,000 | (547,000) | (547,000) | (1,684,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 77,000 | (547,000) | (547,000) | (1,684,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $77,000 | ($547,000) | ($547,000) | ($1,684,000) |
|
0.51% Nasdaq 0.00%
Income Statement
